Answers are grounded in this paper and cite their sources.
Glaucoma is a neurodegenerative disease characterized by permanent visual field loss caused by the death of retinal ganglion cells (RGCs). Glaucoma is the leading cause of irreversible blindness worldwide. We investigated the potential of transplanting human induced pluripotent stem cell-derived RGCs (hiPSC-RGCs) in two mouse models of optic nerve degeneration: N-Methyl-D-Aspartate (NMDA) and optic nerve crush (ONC), and characterized their ability to survive, integrate, and form synaptic connections in a degenerated retina. Follow-up studies, including immunohistochemistry and patch-clamping experiments, one year after intravitreal injections, determined the location, identity, and function of the donor GFP+ve fluorescent cells within the mouse retinas and their similarity to native RGCs. Upon closer inspection, some GFP+ve cells detected in a few retinal sections did not stain for the human-specific marker and were detected in retinal layers outside the expected ganglion cell layer (GCL)/ inner nuclear layer (INL) regions. These findings highlight complications in the interpretation of RGC transplantation studies.
No takes yet. Share an insight, caveat, or question.
Vrathasha et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: